Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ability of whole-genome SNP arrays to capture 'must have' pharmacogenomic variants.

Literature DB >> 19018710

Ability of whole-genome SNP arrays to capture 'must have' pharmacogenomic variants.

Eric J Peters, Howard L McLeod.

Abstract

Mesh：

Substances：

Year: 2008 PMID： 19018710 DOI： 10.2217/14622416.9.11.1573

Source DB: PubMed Journal: Pharmacogenomics ISSN： 1462-2416 Impact factor: 2.533

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. Assessment of a pharmacogenomic marker panel in a polypharmacy population identified from electronic medical records.

Authors: Matthew T Oetjens; Joshua C Denny; Marylyn D Ritchie; Niloufar B Gillani; Danielle M Richardson; Nicole A Restrepo; Jill M Pulley; Holli H Dilks; Melissa A Basford; Erica Bowton; Dan R Masys; Russell A Wilke; Dan M Roden; Dana C Crawford
Journal: Pharmacogenomics Date: 2013-05 Impact factor: 2.533

2. Minimum information required for a DMET experiment reporting.

Authors: Judit Kumuthini; Mamana Mbiyavanga; Emile R Chimusa; Jyotishman Pathak; Panu Somervuo; Ron Hn Van Schaik; Vita Dolzan; Clint Mizzi; Kusha Kalideen; Raj S Ramesar; Milan Macek; George P Patrinos; Alessio Squassina
Journal: Pharmacogenomics Date: 2016-08-22 Impact factor: 2.533

10. The Eleventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Ponte di Legno, Italy, 6-7 May 2009.

Authors: A Biondi; A Baruchel; S Hunger; G Masera; K Schmiegelow; M Schrappe; C H Pui
Journal: Leukemia Date: 2009-11-05 Impact factor: 11.528

Ability of whole-genome SNP arrays to capture 'must have' pharmacogenomic variants.

1. Assessment of a pharmacogenomic marker panel in a polypharmacy population identified from electronic medical records.

2. Minimum information required for a DMET experiment reporting.

3. The limits of genome-wide methods for pharmacogenomic testing.

4. Genetic Polymorphisms of Pharmacogenes among the Genetically Isolated Circassian Subpopulation from Jordan.

Review 5. Genome-wide association studies in pharmacogenomics: successes and lessons.

Review 6. Personalizing medicine with clinical pharmacogenetics.

7. Whole genome amplification of DNA for genotyping pharmacogenetics candidate genes.

8. The need to shift pharmacogenetic research from candidate gene to genome-wide association studies.

9. Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China.

10. The Eleventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Ponte di Legno, Italy, 6-7 May 2009.